Φορτώνει......
Azithromycin and the microbiota of cystic fibrosis sputum
BACKGROUND: Azithromycin is commonly prescribed drug for individuals with cystic fibrosis (CF), with demonstrated benefits in reducing lung function decline, exacerbation occurrence and improving nutrition. As azithromycin has antimicrobial activity against components of the uncultured microbiome an...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | BMC Microbiol |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BioMed Central
2021
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8008652/ https://ncbi.nlm.nih.gov/pubmed/33784986 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12866-021-02159-5 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|